These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients. Ebert W, Muley T, Herb KP, Schmidt-Gayk H. Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610 [Abstract] [Full Text] [Related]
4. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D. Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784 [Abstract] [Full Text] [Related]
5. Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report. Shimozuma K, Sonoo H, Fukunaga M, Ichihara K, Aoyama T, Tanaka K. Jpn J Clin Oncol; 1999 Jan; 29(1):16-22. PubMed ID: 10073146 [Abstract] [Full Text] [Related]
7. Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer? Bombardieri E, Martinetti A, Miceli R, Mariani L, Castellani MR, Seregni E. Eur J Nucl Med; 1997 Nov; 24(11):1349-55. PubMed ID: 9371866 [Abstract] [Full Text] [Related]
10. Bone metabolic markers in the evaluation of bone scan flare phenomenon in bone metastases of breast cancer. Koizumi M, Matsumoto S, Takahashi S, Yamashita T, Ogata E. Clin Nucl Med; 1999 Jan; 24(1):15-20. PubMed ID: 9890487 [Abstract] [Full Text] [Related]
12. Prognostic value of the bone turnover markers in multiple myeloma. Auzina D, Erts R, Lejniece S. Exp Oncol; 2017 Mar; 39(1):53-56. PubMed ID: 28361850 [Abstract] [Full Text] [Related]
15. Biochemical markers for assessment of bone metastases in patients with breast cancer. Hou MF, Tsai LY, Tsai SM, Huang CJ, Huang YS, Hsieh JS, Chan HM, Wang JY, Chuang CH, Chen FM, Huang TJ. Kaohsiung J Med Sci; 1999 Aug; 15(8):452-60. PubMed ID: 10518361 [Abstract] [Full Text] [Related]
16. Bone turnover markers in women with early stage breast cancer who developed bone metastases. A prospective study with multivariate logistic regression analysis of accuracy. Lumachi F, Basso SM, Camozzi V, Tozzoli R, Spaziante R, Ermani M. Clin Chim Acta; 2016 Sep 01; 460():227-30. PubMed ID: 27404457 [Abstract] [Full Text] [Related]
18. Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma. Begić A, Kucukalić-Selimović E, Obralić N, Durić O, Lacević N, Skopljak A. Bosn J Basic Med Sci; 2006 Feb 01; 6(1):75-7. PubMed ID: 16533185 [Abstract] [Full Text] [Related]
19. Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer. Reale MG, Santini D, Marchei GG, Manna A, Del Nero A, Bianco V, Marchei P, Frati L. Int J Biol Markers; 1995 Feb 01; 10(1):42-6. PubMed ID: 7629426 [Abstract] [Full Text] [Related]
20. Serum ostase in the follow-up of breast cancer patients. Marchei P, Santini D, Bianco V, Chiodini S, Reale MG, Simeoni F, Marchei GG, Vecchione A. Anticancer Res; 1995 Feb 01; 15(5B):2217-22. PubMed ID: 8572628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]